HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.
Mangraviti A, Raghavan T, Volpin F, Skuli N, Gullotti D, Zhou J, Asnaghi L, Sankey E, Liu A, Wang Y, Lee DH, Gorelick N, Serra R, Peters M, Schriefer D, Delaspre F, Rodriguez FJ, Eberhart CG, Brem H, Olivi A, Tyler B.
Mangraviti A, et al. Among authors: asnaghi l.
Sci Rep. 2017 Nov 2;7(1):14978. doi: 10.1038/s41598-017-14990-w.
Sci Rep. 2017.
PMID: 29097800
Free PMC article.